The Effect of Demineralized Bone Matrix-Calcium Sulfate with Vancomycin on Calcaneal Fracture Healing and Infection Rates: A Prospective Study

Abstract

Background: Displaced intraarticular calcaneal fractures may have a central cancellous bone defect area. We hypothesized that human demineralized bone matrix (DBM) calcium sulfate (CaSO4) might act as a reasonable alternative to autograft in calcaneal fractures. When combined with antibiotic powder, this bone graft substitute also may act as a local antibiotic delivery device. This is the first clinical study evaluating bone healing and complications associated with DBM-calcium sulfate bone graft substitute in the treatment of displaced intraarticular calcaneal fractures with a central cancellous bone defect. Methods: Over a 29-month period, 33 displaced intraarticular calcaneal fractures with central cancellous defects were treated with open reduction and internal fixation (ORIF) and grafting with vancomycin/DBM-calcium sulfate bone graft substitute. Eleven fractures without bone defects were treated with ORIF only. Patient demographics, medical history, and CT fracture classification were recorded. Postoperatively, fractures were monitored every 2 weeks for healing and complications. Results: The mean time to union was 8.2 weeks in the grafted, while the control group mean time to union was 10.4 weeks ( p = 0.0117). Wound problems occurred in five (15%) of the 33 patients with grafting, all in type III fractures with severe soft-tissue swelling, and included two minor wound healing delays, and three serious wound problems. At a mean followup time of 22.4 months, no DBM-calcium sulfate grafted calcaneus demonstrated evidence of osteomyelitis. Conclusions: This is the first study examining human DBM-calcium sulfate bone graft substitute to treat displaced intraarticular calcaneal fractures. Based on these initial data, human DBM-calcium sulfate acted as an acceptable and safe autograft alternative in displaced intraarticular calcaneal fractures with moderate (5 cc to 10 cc) central cancellous bone defects.